Strategies for Multi-Gene Editing and Reduction of Translocations with CRISPR-CPF1 in T Cells for the Development of Improved Cell Therapies

被引：0
|
作者：
Zuris, John A. [1 ]
Bothmer, Anne [1 ]
Viswanathan, Ramya [1 ]
Abdulkerim, Hayat S. [1 ]
Gareau, Ken [1 ]
Winston, Stephen M. [1 ]
Scott, Sean N. [1 ]
Fang, Justin W. [1 ]
Chin, Melissa S. [1 ]
DaSilva, Jennifer A. [1 ]
Wang, Tongyao [1 ]
Gotta, Gregory M. [1 ]
Borges, Christopher M. [1 ]
Harbinski, Fred [1 ]
Marco, Eugenio [1 ]
Wilson, Christopher J. [1 ]
Welstead, G. Grant [1 ]
Myer, Vic E. [1 ]
Fernandez, Cecilia A. [1 ]
机构：
[1] Editas Med, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
208
引用
收藏
页码：105 / 106
页数：2
相关论文
共 49 条
  • [21] CRISPR-Directed In Vitro Gene Editing of Plasmid DNA Catalyzed by Cpf1 (Cas12a) Nuclease and a Mammalian Cell-Free Extract
    Sansbury, Brett M.
    Wagner, Amanda M.
    Nitzan, Erez
    Tarcic, Gabi
    Kmiec, Eric B.
    CRISPR JOURNAL, 2018, 1 (02): : 191 - 202
  • [22] Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
    Rafal Kaminski
    Yilan Chen
    Tracy Fischer
    Ellen Tedaldi
    Alessandro Napoli
    Yonggang Zhang
    Jonathan Karn
    Wenhui Hu
    Kamel Khalili
    Scientific Reports, 6
  • [23] CRISPR-Cas Genome Editing of Gamma-Globin Gene Promoters in Human Hematopoietic Stem and Progenitor Cells Towards Sickle Cell Disease Therapies
    Katta, Varun
    O'Keefe, Kiera
    Lazzarotto, Cicera
    Mayuranathan, Thiyagaraj
    Pruett-Miller, Shondra
    Sharma, Akshay
    Tisdale, John
    Uchida, Naoya
    Yen, Jonathan
    Zhou, Sheng
    Weiss, Mitchell
    Tsai, Shengdar
    MOLECULAR THERAPY, 2020, 28 (04) : 360 - 360
  • [24] Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
    Kaminski, Rafal
    Chen, Yilan
    Fischer, Tracy
    Tedaldi, Ellen
    Napoli, Alessandro
    Zhang, Yonggang
    Karn, Jonathan
    Hu, Wenhui
    Khalili, Kamel
    SCIENTIFIC REPORTS, 2016, 6
  • [25] Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR/Cas9 gene editing
    Kaminski, Rafal
    Chen, Yilan
    Fischer, Tracy
    Tedaldi, Ellen
    Napoli, Alessandro
    Zhang, Yonggang
    Karn, Jonathan
    Hu, Wenhui
    Khalili, Kamel
    JOURNAL OF NEUROVIROLOGY, 2016, 22 : S35 - S35
  • [26] Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing
    Wagner, Dimitrios L.
    Koehl, Ulrike
    Chmielewski, Markus
    Scheid, Christoph
    Stripecke, Renata
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Variegated expression of members of the WC1 pathogen recognition receptor and co-receptor multi-gene family on γδ T cells
    Damani-Yokota, Payal
    Telfer, Jancie C.
    Baldwin, Cynthia L.
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [28] KEAP1 gene editing using CRISPR/Cas9 for therapeutic NRF2 activation in human T cells
    Noel, Sanjeev
    Lee, Sul A.
    Sadasivam, Mohanraj
    Hamad, Abdel Rahim A.
    Rabb, Hamid
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [29] Highly Efficient Multi-Gene Knockout and Transgene Knock-in Using CRISPR-Cas12a in Induced Pluripotent Stem Cells for the Generation of Engineered Cell Immunotherapies
    Zuris, John A.
    Margulies, Carrie M.
    Viswanathan, Ramya
    Edelstein, Jasmine N.
    Pattali, Rithu
    Gareau, Kenneth W.
    Scott, Sean N.
    Lele, Swarali
    Wilson, Aaron C.
    Moon, Jungil I.
    Dilmac, Nejmi
    Friedland, Ari E.
    Morgan, Richard A.
    MOLECULAR THERAPY, 2020, 28 (04) : 102 - 102
  • [30] Editing T cell repertoire by thymic epithelial cell-directed gene transfer abrogates risk of type 1 diabetes development
    Russo, Fabio
    Ruggiero, Eliana
    Curto, Rosalia
    Passeri, Laura
    Sanvito, Francesca
    Bortolomai, Ileana
    Villa, Anna
    Gregori, Silvia
    Annoni, Andrea
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 25 : 508 - 519
12345